Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints

MicroRNAs (miRNAs) are small RNA molecules that modulate gene expression through degradation of specific mRNAs and/or repression of their translation. miRNAs are involved in both physiological and pathological processes, such as apoptosis and cancer. Their presence has been demonstrated in several organisms as well as in viruses. Virus encoded miRNAs can act as viral gene expression regulators, but they may also interfere with the expression of host genes. Viral miRNAs may control host cell proliferation by targeting cell-cycle and apoptosis regulators. Therefore, they could be involved in cancer pathogenesis. Computational prediction of miRNA/target pairs is a fundamental step in these studies. Here, we describe the use of miRiam, a novel program based on both thermodynamics features and empirical constraints, to predict viral miRNAs/human targets interactions. miRiam exploits target mRNA secondary structure accessibility and interaction rules, inferred from validated miRNA/mRNA pairs. A set of genes involved in apoptosis and cell-cycle regulation was identified as target for our studies. This choice was supported by the knowledge that DNA tumor viruses interfere with the above processes in humans. miRNAs were selected from two cancer-related viruses, Epstein-Barr Virus (EBV) and Kaposi-Sarcoma-Associated Herpes Virus (KSHV). Results show that several transcripts possess potential binding sites for these miRNAs. This work has produced a set of plausible hypotheses of involvement of v-miRNAs and human apoptosis genes in cancer development. Our results suggest that during viral infection, besides the protein-based host regulation mechanism, a post-transcriptional level interference may exist. miRiam is freely available for downloading at http://ferrolab.dmi.unict.it/miriam.

[1]  舘田 一博 RNAiを用いた Gene Silencing の新しい展開 , 2004 .

[2]  B. Cullen,et al.  Transcriptional Origin of Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs , 2006, Journal of Virology.

[3]  Z. Klase,et al.  HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression , 2009, Retrovirology.

[4]  Christoph Rodak,et al.  MirZ: an integrated microRNA expression atlas and target prediction resource , 2009, Nucleic Acids Res..

[5]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[6]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[7]  B. Damania DNA tumor viruses and human cancer. , 2007, Trends in microbiology.

[8]  Kyoung-Mee Kim,et al.  Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. , 2009, The Journal of surgical research.

[9]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[10]  G. Meister,et al.  Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas , 2009, Journal of Virology.

[11]  C. Sander,et al.  Identification of microRNAs of the herpesvirus family , 2005, Nature Methods.

[12]  Sang Taek Oh,et al.  Expression of Viral MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma , 2006, Journal of Virology.

[13]  B. Cullen Viruses and microRNAs , 2006, Nature Genetics.

[14]  E. Méndez,et al.  Caspases Mediate Processing of the Capsid Precursor and Cell Release of Human Astroviruses , 2004, Journal of Virology.

[15]  Michael Kertesz,et al.  The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.

[16]  Y. Li,et al.  Incorporating structure to predict microRNA targets. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Kawanishi,et al.  Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. , 2002, Biochemical and biophysical research communications.

[18]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[19]  C. Croce,et al.  MicroRNAs in diseases and drug response. , 2008, Current opinion in pharmacology.

[20]  Mihaela Zavolan,et al.  Virus-encoded microRNAs: novel regulators of gene expression. , 2006, Trends in microbiology.

[21]  S. Pfeffer,et al.  Viruses, microRNAs and cancer , 2006, Oncogene.

[22]  Y. Percherancier,et al.  Cross Talk between PML and p53 during Poliovirus Infection: Implications for Antiviral Defense , 2006, Journal of Virology.

[23]  Y. Honma,et al.  Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2 , 2008, Cancer science.

[24]  Alexandra Schäfer,et al.  Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed , 2006, PLoS pathogens.

[25]  K. Roemer,et al.  Epstein–Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5 , 2007, Nucleic acids research.

[26]  D. Kwong,et al.  An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival , 2008, The Journal of experimental medicine.

[27]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[28]  E. Robertson,et al.  Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 Function , 2006, Journal of Virology.

[29]  Walter Fontana,et al.  Fast folding and comparison of RNA secondary structures , 1994 .

[30]  M. Samols,et al.  Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. , 2007, The Journal of infectious diseases.

[31]  Anton J. Enright,et al.  Identification of Virus-Encoded MicroRNAs , 2004, Science.